Drug profile · INN
viomycin sulfate
VIOCIN SULFATE
viomycin sulfate (VIOCIN SULFATE) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — viomycin sulfate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
viomycin sulfate (VIOCIN SULFATE) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
70S ribosome inhibitor
Primary target: 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is viomycin sulfate?
viomycin sulfate (VIOCIN SULFATE) is a 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for viomycin sulfate?
VIOCIN SULFATE is a marketed brand name for viomycin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of viomycin sulfate?
viomycin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.